Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorini F, Minuto F, Tizianello A
Department of Internal Medicine, University of Genoa, Italy.
J Clin Invest. 1997 Jan 1;99(1):97-105. doi: 10.1172/JCI119139.
To assess the effect of recombinant human growth hormone (rhGH) on muscle protein metabolism in uremic patients with malnutrition, forearm [3H]phenylalanine kinetics were evaluated in six chronically wasted (body weight 79% of ideal weight) hemodialysis (HD) patients in a self-controlled, crossover study. Forearm protein dynamics were evaluated before, after a 6-wk course of rhGH (5 mg thrice weekly) and after a 6-wk washout period. After rhGH: (a) forearm phenylalanine net balance--the difference between phenylalanine incorporation into and phenylalanine release from muscle proteins--decreased by 46% (-8+/-2 vs. -15+/-2 nmol/min x 100 ml at the baseline and -11+/-2 after washout, P < 0.02); (b) phenylalanine rate of disposal, an index of protein synthesis, increased by 25% (25+/-5 vs. 20+/-5 at the baseline and 20+/-4 after washout, P < 0.03); (c) phenylalanine rate of appearance, an index of protein degradation, was unchanged (33+/-5 vs. 35+/-5 at the baseline and 31+/-4 after washout); (d) forearm potassium release declined (0.24+/-0.13 vs. 0.60+/-0.15 microeq/min at the baseline, and 0.42+/-0.20 microeq/min after washout P < 0.03); (e) changes in the insulin-like growth factor binding protein (IGFBP)-1 levels and insulin-like growth factor-I (IGF-I)/IGFBP-3 ratios accounted for 15.1% and 47.1% of the percent variations in forearm net phenylalanine balance, respectively. Together, these two factors accounted for 62.2% of variations in forearm net phenylalanine balance during and after rhGH administration. These data indicate: (a) that rhGH administration in malnourished hemodialysis patients is followed by an increase in muscle protein synthesis and by a decrease in the negative muscle protein balance observed in the postabsorptive state; and (b) that the reduction in net protein catabolism obtained with rhGH can be accounted for by the associated changes in circulating free, but not total, IGF-I levels.
为评估重组人生长激素(rhGH)对营养不良的尿毒症患者肌肉蛋白质代谢的影响,在一项自身对照的交叉研究中,对6例长期消瘦(体重为理想体重的79%)的血液透析(HD)患者进行了前臂[3H]苯丙氨酸动力学评估。在rhGH治疗6周疗程(每周三次,每次5mg)之前、之后以及6周洗脱期之后,对前臂蛋白质动力学进行了评估。rhGH治疗后:(a)前臂苯丙氨酸净平衡——即苯丙氨酸掺入肌肉蛋白与从肌肉蛋白中释放之间的差值——下降了46%(基线时为-8±2与-15±2nmol/min×100ml,洗脱期后为-11±2,P<0.02);(b)苯丙氨酸处置率,作为蛋白质合成的指标,增加了25%(基线时为25±5与20±5,洗脱期后为20±4,P<0.03);(c)苯丙氨酸出现率,作为蛋白质降解的指标,未发生变化(基线时为33±5与35±5,洗脱期后为31±4);(d)前臂钾释放量下降(基线时为0.24±0.13与0.60±0.15微当量/分钟,洗脱期后为0.42±0.20微当量/分钟,P<0.03);(e)胰岛素样生长因子结合蛋白(IGFBP)-1水平的变化以及胰岛素样生长因子-I(IGF-I)/IGFBP-3比值分别占前臂苯丙氨酸净平衡百分比变化的15.1%和47.1%。这两个因素共同占rhGH给药期间及之后前臂苯丙氨酸净平衡变化的62.2%。这些数据表明:(a)在营养不良的血液透析患者中给予rhGH后,肌肉蛋白质合成增加,且在吸收后状态下观察到的负性肌肉蛋白质平衡减少;(b)rhGH导致的净蛋白质分解代谢减少可归因于循环中游离而非总IGF-I水平的相关变化。